Last reviewed · How we verify
FENT group
At a glance
| Generic name | FENT group |
|---|---|
| Also known as | fentanyl group |
| Sponsor | Zulekha Hospitals |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Opioid-Free vs Opioid-Based Anesthesia for Nasal Surgeries (PHASE3)
- Dexmedetomidine Versus Fentanyl as an Adjuvant to Bupivacaine in Saddle Block (NA)
- Comparison Of Dexmedetomidine and Fentanyl In Attenuation Of Hemodynamic Response To Direct Laryngoscopy And Intubation In Patient Undergoing Laparoscopic Cholecystectomy. (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- FENT group CI brief — competitive landscape report
- FENT group updates RSS · CI watch RSS
- Zulekha Hospitals portfolio CI